The apurinic/apyrimidinic endonuclease (APE/ref-1) DNA repair enzyme is elevated in premalignant and malignant cervical cancer

Anticancer Research

Volumn 17, Issue 5 B, 1997, Pages 3713-3719

  Xu, Yi ^a   Moore, David H ^a   Broshears, John ^a   Liu, Lifei ^a   Wilson, Teresa M ^a   Kelley, Mark R ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

APE ref 1; DNA base excision repair; Immunohistochemistry

Indexed keywords

DNA (APURINIC OR APYRIMIDINIC SITE) LYASE; ENDONUCLEASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; POLYDEOXYRIBONUCLEOTIDE SYNTHASE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 1;

ARTICLE; CANCER CELL CULTURE; CELL TYPE; CONTROLLED STUDY; DNA REPAIR; FEMALE; HELA CELL; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; OXIDATION REDUCTION REACTION; PRECANCER; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN EXPRESSION; SQUAMOUS CELL; TISSUE DISTRIBUTION; UTERINE CERVIX CANCER;

ANTIBODY SPECIFICITY; CARBON-OXYGEN LYASES; DEOXYRIBONUCLEASE IV (PHAGE T4-INDUCED); DNA REPAIR; DNA-(APURINIC OR APYRIMIDINIC SITE) LYASE; FEMALE; HUMANS; PRECANCEROUS CONDITIONS; TUMOR CELLS, CULTURED; UTERINE CERVICAL NEOPLASMS;

EID: 0031439376     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Doetsch F and Cunningham R: The enzymology of apurinic/apyrimidinic endonucleases. Muta Res 236: 173-201, 1990.
2. Haring M, Rudige H , Demple F, Boiteux S and Epe B: Recognition of oxidized abasic sites by repair endonucleases. Nucl Acids Res 22: 2010-2015, 1995.
3. Loeb LA: Apurinic sites as mutagenic intermediates. Cell 40: 483-484, 1985.
4. Friedberg EC, Walker GC and Siede W: DNA Repair and Mutagenesis. Washington D C: ASM Press, 1995.
5. Xanthoudakis S and Curran T: Identification and characterization of Ref-1, a nuclear protein that facilitates AP-1 DNA-binding activity. EMBO J 11: 653-65, 1992.
6. Xanthoudakis S, Miao GG and Curran T: The redox and DNA-repair activities of Ref-1 are encoded by nonoverlapping domains. Proceedings of the Nat Acad Sciences USA 91: 23-7, 1994.
7. Okazaki T, Chung U, Nishishita T, Ebisu S, Usuda S, Mishiro S, Xanthoudakis S, Igarashi T and Ogata E: A redox factor protein, ref1, is involved in negative gene regulation by extracellular calcium. J Biol Chem 269, 45: 27855-27862, 1994.
8. Wilson TM, Rivkees SA, Deutsch WA, and Kelley MR: Differential expression of the apurinic/apyrimidinic endonuclease (APE/ref-1) multifunctional DNA base excision repair gene during fetal development and in adult rat brain and testis. Mut Res 362: 237-248, 1996.
9. Duguid JR, Eble JN, Wilson TM and Kelley MR: Differential cellular and subcellular expression of the human multifunctional apurinic/apyrimidinic endonuclease (APE/ref-1) DNA repair enzyme, Cancer Res 55: 6097-102, 1995.
10. Rivkees SA and Kelley MR: Expression of a multifunctional DNA repair enzyme gene, apurinic/apyrimidinic endonuclease (APE; Ref-1) in the suprachiasmatic, supraoptic and paraventricular nuclei. Brain Research 666: 137-42, 1994.
11. Yao KS, Clayton M and PJ OD: Apoptosis in human adenocarcinoma HT29 cells induced by exposure to hypoxia. J Nat Cancer Inst 87: 117-22, 1995.
12. Walker LJ, Craig RB, Harris AL and Hickson ID: A role for the human DNA repair enzyme HAP1 in cellular protection against DNA damaging agents and hypoxic stress. Nucleic Acids Res 22: 4884-9, 1994.
13. Demple B, Herman T and Chen DS: Cloning and expression of APE, the cDNA encoding the major human apurinic endonuclease: definition of a family of DNA repair enzymes. Proc Nat Acad Sciences USA 88: 11450-11454, 1991.
14. Wilson DM. III, Deutsch WA and Kelle MR: Drosophila ribosomal protein S3 contains an activity that cleaves DNA at apurinic/ apyrimidinic sites. J Biol Chem 269: 25359-64, 1994.
15. Wilson TM, Ewel A, Duguid JR, Eble JN, Lescoe MK, Fishel R and Kelley MR: Differential cellular expression of the human MSH2 repair enzyme in small and large intestine. Cancer Res 55: 5146-50, 1995.
16. Scully R, Ganesan S, Brown M, De Caprio JA, Cannistra SA, Feuteun J, Schnitt S and Livingston DM: Location of BRCA1 in human breast and ovarian cancer cells. Science 272: 123-125, 1996.
17. Hubank M and Mayne L: Expression of the excision repair gene, ERCC3 (excision repair cross-complementing), during mouse development. Brain Res Dev Brain Res 81: 66-76, 1994.
18. Yao KS, Xanthoudakis S, Curran T and PJ OD: Activation of AP-1 and of a nuclear redox factor, Ref-1, in the response of HT29 colon cancer cells to hypoxia. Molecular & Cellular Biol 14: 5997-6003, 1994.
19. Yao KS, Clayton M and O'Dwyer PJ: Apoptosis in human adenocarcinoma HT29 cells induced by exposure to hypoxia. J Nat Cancer Inst 87: 117-122, 1995.
20. Harrison L, Galanopoulos T, Ascion AG, Antoniades HN and Demple B: Regulated expression of APE apurinic enodnuclease mRNA during wound healing in porcine epidermis. Carcinogenesis 17: 377-381, 1996.
21. Robertson KA, Hill DP, Xu Y, Liu L, VanEpps S, Hockenbery DM, Park JR, Wilson TM and Kelley MR: Downregulation of apurinic/apyrimidinic endonuclease expression is associated with the induction of apoptosis in differentiating myeloid leukemia cells. Cell Growth Different 8: 443-449, 1997.
22. Yen L, Woo A, Christopoulopoulos G, Batist G, Panasci L, Ro R, Mitra S and Alaoui-Jamali MA: Enhanced host cell reactivation capacity and expression of DNA repair genes in human breast cancer cells resistant to bi-functional alkylating agents. Mutat Res 337: 179-89, 1995.
23. Park TW, Fujiwara H and Wright TC: Molecular biology of cervical cancer and its precursors. Cancer 76: 1902-1913, 1995.
24. Schiffman MH and Brinton LA: The epidemiology of cervical carcinogenesis. Cancer 76: 1888-1901, 1995.
25. Koss LG: Cervical (Pap) smear; new directions. Cancer 71: 1406-12, 1993.
26. Mitchell MF, Hittelman WK, Lotan R, Nishioka K, Tortolero-Luna G, Richards Kortum, R, Warton JT and Hong WK: Chemoprevention trials and surrogate end point biomarkers in the cervix. Cancer 76: 1956-77, 1995.
27. Morell ND, Taylor JR, Snyder RN, Ziel HK, Saltz A and Willie S: Falsenegative cytology rates in patients in whom invasive cervical cancer subsequently developed. Obstet Gynecol 60: 41-45, 1982.